Analysts' Recommendation: Buy 30 Days Ago: Buy Analysts' Target: $76 Analysts' Targets Deutsche Bank Securities $73 Neutral Thursday, July 10, 2008 Leerink Swann & Company $76 Mkt Perform Monday, June 23, 2008 Robert W. Baird & Co. $80 Hold Thursday, January 24, 2008 Stryker Corporation, together with its subsidiaries, operates as a medical technology company worldwide. It operates in two segments, Orthopaedic Implants and MedSurg Equipment. The Orthopedic Implants segment provides orthopedic reconstructive, spinal, and craniomaxillofacial implant systems, as well as trauma implant systems, joint replacement products, knee implant systems, hip implant systems, bone cement, and OP-1 implants. The MedSurg Equipment segment offers surgical equipment; surgical navigation systems; endoscopic, communications, and digital imaging systems; and patient handling and emergency medical equipment. Stryker Corporation sells its products through local dealers and direct sales force to hospitals, health-care facilities, and doctors. The company was founded in 1941 and is headquartered in Kalamazoo, Michigan.